The Asia Pacific peptide therapeutics market is expected to reach US$ 10,565.67 million by 2027 from US$ 4,986.73 million in 2019; it is estimated to grow at a CAGR of 9.9% from 2020 to 2027.
The growth of the Asia Pacific peptide therapeutics market is attributed to key driving factors, such as growing investments in peptide therapeutics and increasing prevalence of metabolic disorders and infectious diseases. However, operational limitations of peptides are expected to restrain the growth of the Asia Pacific peptide therapeutics market during the forecast period.
Peptides are naturally occurring biological molecules that play a prominent role in important biological activities. Continuous R&D activities in peptide therapeutics have discovered its benefits in tackling a range of chronic disorders, such as renal disorders, genetic conditions, oncology, and neurodegenerative conditions. Over 7,000 naturally occurring peptides have been identified in recent years, which have crucial roles in human physiology, including actions as neurotransmitters, hormones, ion channel ligands, and growth factors. The effectiveness of the outcomes of peptide therapies is generating investments in the development of new drugs. Also, increasing prevalence of metabolic and infectious diseases is one of the prominent factors expected to drive the peptide therapeutics market. An estimated 1.2 million Australians (4.9% of the total population) were suffering from diabetes in 2018, based on self-reported data from the Australian Bureau of Statistics. Hence, increase in investments in the development of new drugs for peptide therapies and applicability of therapies for treatment of viral infections and chronic diseases are expected to accelerate the growth of the peptide therapeutics market during the forecast period.
The outbreak of the COVID-19 pandemic has extensively affected the countries in the Asia Pacific region. However, growing research on peptide therapies to treat COVID-19 patients is likely to favor the market growth. For instance, in September 2020, a research study called “The Potential of Antiviral Peptides as COVID-19 Therapeutics” was conducted at the University of Nottingham, Malaysia. Thus, growing research on peptide therapies is expected to positively impact the peptide therapeutics market during the forecast period.
Based on type, the Asia Pacific peptide therapeutics market is segmented into generic and innovative. The innovative segment held the largest share of the market in 2019, whereas the generic segment is anticipated to register the highest CAGR in the market during the forecast period.
Asia PacificPeptide Therapeutics MarketRevenue and Forecast to 2027 (US$ Mn)
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Asia Pacific Peptide Therapeutics MarketSegmentation
By Type
- Innovative
- Generic
By Route of Administration
- Parenteral
- Mucosal
- Oral
- Pulmonary
- Others
By Synthesis Technology
- Solid Phase Peptide Synthesis (SPPS)
- Liquid Phase Peptide Synthesis (LPPS)
- Hybrid Technology
By Application
- Cancer
- Metabolic Disorder
- Cardiovascular Disorder
- Respiratory Disorder
- Pain
- Dermatology
By Country
- India
- Japan
- China
- South Korea
- Australia
- Rest of Asia Pacific
Company Profiles
- Amgen Inc.
- Eli Lilly and Company
- EVER Pharma GmbH
- Polypeptide Group
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- AstraZeneca
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Novo Nordisk A/S
- Sanofi
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Type, Route of Administration, Synthesis Technology, Application, and Country
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Australia, China, Japan, South Korea
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Asia Pacific Peptide Therapeutics Market – By Type
1.3.2 Asia Pacific Peptide Therapeutics Market – By Route of Administration
1.3.3 Asia Pacific Peptide Therapeutics Market – By Synthesis Technology
1.3.4 Asia Pacific Peptide Therapeutics Market – By Application
1.3.5 Asia Pacific Peptide Therapeutics Market – By Country
2. Peptide Therapeutics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Peptide Therapeutics – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Asia Pacific – PEST Analysis
4.3 Expert Opinion
5. Peptide Therapeutics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Investments on Peptide Therapeutics
5.1.2 Increasing Prevalence of Metabolic Disorders and Infectious Diseases
5.2 Market Restraints
5.2.1 Operational Limitations of Peptides
5.3 Market Opportunities
5.3.1 Strong Pipeline and Applications of Peptide Drugs
5.4 Future Trends
5.4.1 Emphasis on Automatic Peptide Synthesis
5.5 Impact Analysis
6. Peptide Therapeutics Market – Asia Pacific Analysis
6.1 Asia Pacific Peptide Therapeutics Market Revenue Forecast and Analysis
7. Peptide Therapeutics Market Analysis – By Type
7.1 Overview
7.2 Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
7.3 Generic
7.3.1 Overview
7.3.2 Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
7.4 Innovative
7.4.1 Overview
7.4.2 Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8. Peptide Therapeutics Market Analysis – By Route of Administration
8.1 Overview
8.2 Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
8.3 Parenteral
8.3.1 Overview
8.3.2 Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Oral
8.4.1 Overview
8.4.2 Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.5 Mucosal
8.5.1 Overview
8.5.2 Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.6 Pulmonary
8.6.1 Overview
8.6.2 Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
8.7 Others
8.7.1 Overview
8.7.2 Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9. Peptide Therapeutics Market Analysis – By Synthesis Technology
9.1 Overview
9.2 Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
9.3 Solid Phase Peptide Synthesis (SPPS)
9.3.1 Overview
9.3.2 Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Liquid Phase Peptide Synthesis (LPPS)
9.4.1 Overview
9.4.2 Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Hybrid Technology
9.5.1 Overview
9.5.2 Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
10. Peptide Therapeutics Market– Application
10.1 Overview
10.2 Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
10.3 Cancer
10.3.1 Overview
10.3.2 Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.4 Cardiovascular Disorders
10.4.1 Overview
10.4.2 Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.5 Metabolic Disorder
10.5.1 Overview
10.5.2 Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.6 Respiratory Disorders
10.6.1 Overview
10.6.2 Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.7 Pain
10.7.1 Overview
10.7.2 Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
10.8 Dermatology
10.8.1 Overview
10.8.2 Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
11. Peptide Therapeutics Market – Asia Pacific Analysis
11.1 Asia Pacific: Peptide Therapeutics Market
11.1.1 Overview
11.1.2 Asia Pacific: Peptide Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.3 Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.4 Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.5 Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.6 Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.7 Asia Pacific: Peptide Therapeutics Market, by Country, 2019& 2027 (%)
11.1.8 China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 China: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.8.3 China: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.8.4 China: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.8.5 China: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.9 Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Japan: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.9.3 Japan: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.9.4 Japan: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.9.5 Japan: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.10 India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 India: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.10.3 India: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.10.4 India: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.10.5 India: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.11 South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.1 South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.11.2 South Korea: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.11.3 South Korea: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.11.4 South Korea: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.11.5 South Korea: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.12 Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Australia: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.12.3 Australia: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.12.4 Australia: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.12.5 Australia: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
11.1.13 Rest of Asia Pacific: Peptide Therapeutics Market Revenue and Forecasts to 2027 (US$ Mn)
11.1.13.1 Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts to 2027 (USD Million)
11.1.13.2 Rest of Asia Pacific: Peptide Therapeutics Market, by Type, 2018–2027 (USD Million)
11.1.13.3 Rest of Asia Pacific: Peptide Therapeutics Market, by Route of Administration, 2018–2027 (USD Million)
11.1.13.4 Rest of Asia Pacific: Peptide Therapeutics Market, by Synthesis Technology, 2018–2027 (USD Million)
11.1.13.5 Rest of Asia Pacific: Peptide Therapeutics Market, by Application, 2018–2027 (USD Million)
12. Impact of COVID-19 Pandemic on Asia Pacific Peptide Therapeutics Market
12.1 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
13. Company Profiles
13.1 Amgen Inc.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 EVER Pharma GmbH
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Polypeptide Group
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 TEVA PHARMACEUTICAL INDUSTRIES LTD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 AstraZeneca
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Bristol-Myers Squibb Company
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 GlaxoSmithKline plc.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Novo Nordisk A/S
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Sanofi
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 2. Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 3. Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 4. Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 5. China Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 6. China Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 7. China Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 8. China Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 9. Japan Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 10. Japan Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 11. Japan Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 12. Japan Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 13. India Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 14. India Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 15. India Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 16. India Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 17. South Korea Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 18. South Korea Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 19. South Korea Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 20. South Korea Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 21. Australia Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 22. Australia Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 23. Australia Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 24. Australia Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 25. Rest of Asia Pacific Peptide Therapeutics Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 26. Rest of Asia Pacific Peptide Therapeutics Market, by Route of Administration – Revenue and Forecast to 2027 (USD Million)
Table 27. Rest of Asia Pacific Peptide Therapeutics Market, by Synthesis Technology – Revenue and Forecast to 2027 (USD Million)
Table 28. Rest of Asia Pacific Peptide Therapeutics Market, by Application – Revenue and Forecast to 2027 (USD Million)
Table 29. Glossary of Terms, Peptide Therapeutics Market
LIST OF FIGURES
Figure 1. Peptide Therapeutics Market Segmentation
Figure 2. Peptide Therapeutics Market Segmentation, By Country
Figure 3. Asia Pacific Peptide Therapeutics Market Overview
Figure 4. Innovative Segment Held Largest Share of Peptide Therapeutics Market
Figure 5. Asia Pacific Peptide Therapeutics Market – Leading Country Markets (US$ Million)
Figure 6. Asia Pacific PEST Analysis
Figure 7. Peptide Therapeutics Market Impact Analysis of Drivers and Restraints
Figure 8. Asia Pacific Peptide Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027
Figure 9. Peptide Therapeutics Market Revenue Share, by Type (2019 and 2027)
Figure 10. Generic: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 11. Innovative: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 12. Peptide Therapeutics Market Revenue Share, by Route of Administration (2019 and 2027)
Figure 13. Parenteral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 14. Oral: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 15. Mucosal: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 16. Pulmonary: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 17. Others: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 18. Peptide Therapeutics Market Revenue Share, by Synthesis Technology (2019 and 2027)
Figure 19. Solid Phase Peptide Synthesis (SPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Liquid Phase Peptide Synthesis (LPPS): Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21. Hybrid Technology: Peptide Therapeutics Market – Revenue and Forecast to 2027 (US$ Million)
Figure 22. Peptide Therapeutics Market Share, Application, 2019 and 2027 (%)
Figure 23. Cancer: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 24. Cardiovascular Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 25. Metabolic Disorder: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 26. Respiratory Disorders: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 27. Pain: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 28. Dermatology: Peptide Therapeutics Market Market– Revenue and Forecast to 2027 (US$ million)
Figure 29. Asia Pacific: Peptide Therapeutics Market, by Key Country – Revenue (2019) (USD Million)
Figure 30. Asia Pacific Peptide Therapeutics Market Revenue and Forecast to 2027 (USD Million)
Figure 31. China: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 32. Japan: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 33. India: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 34. South Korea: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 35. Australia: Peptide Therapeutics Market – Revenue and Forecast to 2027 (USD Million)
Figure 36. Rest of Asia Pacific: Peptide Therapeutics Market- Revenue and Forecasts To 2027 (USD Million)
Figure 37. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
- Amgen Inc.
- Eli Lilly and Company
- EVER Pharma GmbH
- Polypeptide Group
- TEVA PHARMACEUTICAL INDUSTRIES LTD
- AstraZeneca
- Bristol-Myers Squibb Company
- GlaxoSmithKline plc
- Novo Nordisk A/S
- Sanofi
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Asia Pacific Peptide Therapeutics Market
Mar 2021
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Mar 2021
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Mar 2021
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Mar 2021
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Mar 2021
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Mar 2021
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Mar 2021